ArticleJournal of experimental & clinical cancer research : CR2025
Correction: Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma.
Jin Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.